Dr. Schiel is a research chemist in the NIST Biomolecular Measurement Division and on detail to the Advanced Manufacturing National Program Office (AMNPO) as the Technical Program Manager for NIIMBL, the National Institute for Innovation in Manufacturing Biopharmaceuticals (the NIST-sponsored Manufacturing USA institute). He received his BS and Ph.D. in chemistry from the University of Nebraska-Lincoln.
Dr. Schiel coordinates the development of Reference Materials that support the biomanufacturing industry, including the recombinant IgG1κ NIST monoclonal antibody Reference Material 8671 (NISTmAB). He also leads an analytical research team developing innovative approaches toward production/characterization of next generation biotherapeutics (e.g. viral vectors, cell therapy products, and vaccines) and de-risking of innovative technologies for lifecycle appropriate implementation and regulatory assimilation.
He is an author of over 30 publications, an editor of the ACS book series “State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization”, and recipient of numerous Awards including the Arthur S. Flemming Award, Department of Commerce Gold Medal, ACS Division of Analytical Chemistry Fellowship, Bioanalysis Young Investigator Award, and UNL Early Achiever Award.
As the NIIMBL Technical Program Manager, he provides technical leadership to manage the NIIMBL-funded American Rescue Plan projects covering coronavirus response research, collaborates with NIST lab programs on opportunities to leverage NIIMBL, and advises the institute on technology and workforce development projects.